Jeff Macdonald | Head, Investor & Public Relations |
Mark Velleca | CEO, President & Director |
Rajesh Malik | Chief Medical Officer and SVP, R&D |
Jennifer Moses | CFO |
Dane Leone | Raymond James & Associates |
Anupam Rama | JPMorgan Chase & Co. |
Chris Shibutani | Cowen and Company |
Chad Messer | Needham & Company |
Thomas Shrader | BTIG |
Good afternoon, ladies and gentlemen, and welcome to the G1 Therapeutics Third Quarter 2019 Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Mr. Jeff Macdonald, Head of Investor Relations for G1 Therapeutics.